StockData
Perspective Therapeutics, Inc. logo

Perspective Therapeutics, Inc. (CATX) stock

CATXNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/30
$0.75−0.03 (-3.85%)

Close on Nov 20, 2026Market cap $86.05MP/E –Yield –

Perspective Therapeutics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Perspective Therapeutics's revenue for the twelve months ending Jun 30, 2022 was $10.80M, up 7.4% year over year. For fiscal 2022 it was $10.80M, up 7.4% from the year before. Over ten years it grew 7.8% a year on average. The highest annual figure on record is $10.80M in fiscal 2022.

Annual revenue

PeriodPeriod endValueChange
FY2022Jun 30, 2022$10.80M+7.4%
FY2021Jun 30, 2021$10.05M+3.9%
FY2020Jun 30, 2020$9.68M+32.3%
FY2019Jun 30, 2019$7.31M+23.5%
FY2018Jun 30, 2018$5.92M+24.4%
FY2017Jun 30, 2017$4.76M-0.2%
FY2016Jun 30, 2016$4.77M+3.5%
FY2015Jun 30, 2015$4.61M+9.2%
FY2014Jun 30, 2014$4.22M-6.8%
FY2013Jun 30, 2013$4.53M-10.8%
FY2012Jun 30, 2012$5.07M-3.2%
FY2011Jun 30, 2011$5.24M–

Quarterly revenue

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2022CQ2 2022Jun 30, 2022$2.51M-7.6%
Q3 FY2022CQ1 2022Mar 31, 2022$2.91M+11.9%
Q2 FY2022CQ4 2021Dec 31, 2021$2.82M+19.4%
Q1 FY2022CQ3 2021Sep 30, 2021$2.56M+7.6%
Q4 FY2021CQ2 2021Jun 30, 2021$2.71M+18.9%
Q3 FY2021CQ1 2021Mar 31, 2021$2.60M-9.7%
Q2 FY2021CQ4 2020Dec 31, 2020$2.36M+6.9%
Q1 FY2021CQ3 2020Sep 30, 2020$2.38M+3.0%
Q4 FY2020CQ2 2020Jun 30, 2020$2.28M+18.5%
Q3 FY2020CQ1 2020Mar 31, 2020$2.88M+49.7%
Q2 FY2020CQ4 2019Dec 31, 2019$2.21M+15.9%
Q1 FY2020CQ3 2019Sep 30, 2019$2.32M+48.2%
Q4 FY2019CQ2 2019Jun 30, 2019$1.92M+20.0%
Q3 FY2019CQ1 2019Mar 31, 2019$1.92M+22.3%
Q2 FY2019CQ4 2018Dec 31, 2018$1.90M+24.0%
Q1 FY2019CQ3 2018Sep 30, 2018$1.56M+29.0%
Q4 FY2018CQ2 2018Jun 30, 2018$1.60M+17.0%
Q3 FY2018CQ1 2018Mar 31, 2018$1.57M+22.7%
Q2 FY2018CQ4 2017Dec 31, 2017$1.54M+49.4%
Q1 FY2018CQ3 2017Sep 30, 2017$1.21M+12.0%
Q4 FY2017CQ2 2017Jun 30, 2017$1.37M+22.3%
Q3 FY2017CQ1 2017Mar 31, 2017$1.28M+7.0%
Q2 FY2017CQ4 2016Dec 31, 2016$1.03M-13.5%
Q1 FY2017CQ3 2016Sep 30, 2016$1.08M-14.3%
Q4 FY2016CQ2 2016Jun 30, 2016$1.12M-16.5%
Q3 FY2016CQ1 2016Mar 31, 2016$1.20M+3.4%
Q2 FY2016CQ4 2015Dec 31, 2015$1.19M–
Q1 FY2016CQ3 2015Sep 30, 2015$1.26M–
Q4 FY2015CQ2 2015Jun 30, 2015$1.34M–
Q3 FY2015CQ1 2015Mar 31, 2015$1.16M–

More Perspective Therapeutics figures

See a number that looks wrong?